As of June 21, 2025, Intec Pharma Ltd (NTEC) reports a Forward P/E of 1.78.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Intec Pharma Ltd's Forward P/E to Peers
To better understand Intec Pharma Ltd's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Intec Pharma Ltd (NTEC) | 1.78 |
| Kamada Ltd (KMDA) | 23.56 |
Compared to its competitors, Intec Pharma Ltd's Forward P/E is lower than all peers, which may suggest undervaluation or market concerns about future earnings.